Bach P, Franck J, Hällgren J, Widing H, Gissler M, Westman J. Association of GLP-1 receptor agonists with alcohol use disorder-related and substance use disorder-related hospital admissions during treatment and after discontinuation: a Swedish register-based within-individual observational study. Lancet Psychiatry. 2026 13(8):669-677.
Bach P, Franck J, Hällgren J, Widing H, Gissler M, Westman J. Prescription psychostimulants or atomoxetine and the risk of stimulant-related hospital admissions in adults with and without stimulant use disorder: a Swedish population-based within-individual observational study. Lancet Reg Health Eur. 2026 65:101658.
Geissler CJ, Lim TV, Görne HA, Krenkel S, Büchel C, Ersche KD. Increased Avoidance Learning in Chronic Opioid Users. JAMA Psychiatry. 2026 83(3):292-297. Epub 2025 Nov 6.
Hoertel N, Mühle C, Müller CP, Chaieb H, Scheer V, Fayad M, Sánchez-Rico M, Limosin F, Kornhuber J. The role of sphingolipids in major depressive disorder and associated cognitive impairment: interactions with monoaminergic signaling, neuroinflammation, and neurogenesis. Mol Psychiatry. 2026 31(10):5667-5680. Epub 2026 May 13.
Rötzer L, Zaiser J, Hoffmann S, Hiß I, Reinhard I, Heim C, Tost H, Kiefer F, Lenz B, Bach P. Sex-Moderated and Sex-Specific Effects of Adverse Childhood Experiences on Neural Alcohol Cue Reactivity and Daily Craving in Individuals With Alcohol Use Disorder. Am J Psychiatry. 2026 Sep 9. [Epub ahead of print] :appiajp20251163.